Solvay To Submit Audits To FDA Shortly In Effort To Be Removed From AIP List

Solvay has indicated that the independent audits analyzing stability data generated by its manufacturing facilities will be submitted shortly to FDA as a step in being removed from the agency's application integrity policy list.